These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35061863)

  • 1. Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis.
    Li S; Wang X; Li Q; Li C
    Oncol Lett; 2023 Jan; 25(1):19. PubMed ID: 36478896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 is involved in the occurrence, development and prognosis of cancer.
    Li S; Qu J; Wang X; Zou Q; Li C
    Oncol Lett; 2023 Sep; 26(3):393. PubMed ID: 37600341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.
    Liu S; Chen S; Ma K; Shao Z
    Cancer Cell Int; 2018; 18():166. PubMed ID: 30386175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 6. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.
    Jiang C; Hu F; Tai Y; Du J; Mao B; Yuan Z; Wang Y; Wei L
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):637-46. PubMed ID: 22228034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
    Wu P; Wu D; Li L; Chai Y; Huang J
    PLoS One; 2015; 10(6):e0131403. PubMed ID: 26114883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of SHP2 in gastric cancer.
    Dong S; Li FQ; Zhang Q; Lv KZ; Yang HL; Gao Y; Yu JR
    J Int Med Res; 2012; 40(6):2083-9. PubMed ID: 23321164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
    Huang Y; Wang J; Cao F; Jiang H; Li A; Li J; Qiu L; Shen H; Chang W; Zhou C; Pan Y; Lu Y
    Sci Rep; 2017 Dec; 7(1):17597. PubMed ID: 29242509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
    Xu M; Xu S
    Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
    Chen L; Xie Y; Li X; Gu L; Gao Y; Tang L; Chen J; Zhang X
    Onco Targets Ther; 2017; 10():2849-2863. PubMed ID: 28652767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
    Front Physiol; 2018; 9():452. PubMed ID: 29765332
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis.
    Liu Y; Tang W; Xie L; Wang J; Deng Y; Peng Q; Zhai L; Li S; Qin X
    Tumour Biol; 2014 Apr; 35(4):3145-54. PubMed ID: 24258111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    Medicine (Baltimore); 2022 Oct; 101(40):e30826. PubMed ID: 36221386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
    Front Immunol; 2020; 11():1242. PubMed ID: 32714321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.